Abstract

Participant Accrual and Retention Unit (PAR). The HNRC cohort, recruited and retained by the PAR Unit, consists of approximately 300 HIV+ individuals and HIV- controls who have undergone prospective, multidisciplinary evaluation. Data from this cohort are the foundation for the Center's scientific productivity, including presentafions, publications, and preliminary investigations that have led to development of R01s and other peer review grants associated with the HNRC. The PAR Unit maintained a directory of research participants that served the dual purpose of identifying participants who might be suitable for specific research programs, while also preventing overuse of such participants. Training by the PAR Unit in participant identification, recruitment, obtaining informed consent, including determining capacity to provide consent for cognitively impaired persons, helped launch and sustain successful recruitment efforts in many other studies.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH062512-15
Application #
8829918
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
15
Fiscal Year
2015
Total Cost
Indirect Cost

  Institution

Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093

  Publications

Walker, Rheeda L; Hong, Judy H; Talavera, David C et al. (2018) Health literacy and current CD4 cell count in a multiethnic U.S. sample of adults living with HIV infection. Int J STD AIDS 29:498-504
Heldt, Sven; Prattes, Juergen; Eigl, Susanne et al. (2018) Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect 77:235-241
Jenks, Jeffrey Daniel; Hoenigl, Martin (2018) CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy. J Lab Precis Med 3:
Ocque, Andrew J; Hagler, Colleen E; Morse, Gene D et al. (2018) Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid. J Pharm Biomed Anal 156:163-169
Soontornniyomkij, Virawudh; Umlauf, Anya; Soontornniyomkij, Benchawanna et al. (2018) Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS 32:2005-2015
Moore, Raeanne C; Hussain, Mariam A; Watson, Caitlin W-M et al. (2018) Grit and Ambition are Associated with Better Neurocognitive and Everyday Functioning Among Adults Living with HIV. AIDS Behav 22:3214-3225
Patel, Atul K; Patel, Ketan K; Gohel, Swati et al. (2018) Incidence of symptomatic CSF viral escape in HIV infected patients receiving atazanavir/ritonavir (ATV/r)-containing ART: a tertiary care cohort in western India. J Neurovirol 24:498-505
Kanmogne, Georgette D; Fonsah, Julius Y; Tang, Bin et al. (2018) Effects of HIV on executive function and verbal fluency in Cameroon. Sci Rep 8:17794
Kabuba, Norma; Menon, J Anitha; Franklin, Donald R et al. (2018) Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults. Neuropsychology 32:519-528
Gianella, Sara; Marconi, Vincent C; Berzins, Baiba et al. (2018) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr 79:e112-e114

Showing the most recent 10 out of 743 publications